Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
BeiGene
BeiGene
GlaxoSmithKline
Merck Sharp & Dohme LLC
Gilead Sciences
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Ludwig Institute for Cancer Research
GSO Global Clinical Research BV
National Institutes of Health Clinical Center (CC)
Fox Chase Cancer Center
Gilead Sciences
mAbxience Research S.L.
Eli Lilly and Company
Progen Pharmaceuticals
Pfizer